Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Endophenotyping With fMRI: Genetic Modulation and Treatment Response

NCT01503931 is registered in ClinicalTrials.gov with Charite University, Berlin, Germany as lead sponsor.

NCT NCT01503931
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01503931 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Endophenotyping With fMRI: Genetic Modulation and Treatment Response
Lead sponsor
Charite University, Berlin, Germany
Phase
Observational
Overall status
Completed
Start date
June 30, 2008
Completion date
June 30, 2013
Enrollment
480 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alcohol dependence